[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"low-density-lipoprotein-cholesterol-level\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:low-density-lipoprotein-cholesterol-level":74},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100646963","electronic-health-record-augmented-ldl-cholesterol-optimization-and-control-via-active-lipid-engagement-ehr-locale-a-quality-improvement-implementation-study-100646963",false,"NCT07685639","Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study","EHR-LOCALE","Inclusion Criteria:\n\n1. Adults over the age of 18\n2. Resident of Alberta\n3. Individuals hospitalized with an acute coronary syndrome and have undergone coronary angiography.\n4. Able to participate in follow-up contact if randomized to the intervention arm\n\nExclusion Criteria:\n\n1\\. In-hospital mortality","ALL",{"count":18,"type":19},2000,"ESTIMATED","INTERVENTIONAL",[22],"NA","The purpose of this study is to determine whether a proactive, EHR-guided approach helps more individuals reach safe cholesterol levels, improves medication use, and reduces future heart attacks and strokes, compared to usual care.\n\nThe main question it aims to answer is:\n\n• Does the EHR-LOCALE pathway increases the proportion of patients who reach the LDL-cholesterol target of \\\u003C1.8 mmol\u002FL at 6 months?\n\nParticipants in the interventional group receive:\n\n* Pharmacist contact\n* Repeat lipid requisitions\n* Review of medications, adherence, and side effects\n* Treatment escalation according to national dyslipidemia guidelines",[25,26,27,28],"ACS (Acute Coronary Syndrome)","Hyperlipidemia","Dyslipidemia","Low-Density-Lipoprotein-cholesterol Level",[27,30,31,32,33,34],"Canadian VIGOUR Centre","LDL","ACS","triglycerides","lipid","NOT_YET_RECRUITING","2026-06-29",{"date":38,"type":39},"2026-07-06","ACTUAL",{"date":41,"type":19},"2026-08",{"date":43,"type":19},"2027-09",{"name":45,"class":46},"University of Alberta","OTHER",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":73},"100615904","cardiovascular-risk-factors-in-middle-eastern-patients-with-stroke-100615904","NCT07298668","Cardiovascular Risk Factors in Middle Eastern Patients With Stroke","Standard Modifiable Risk Factors in Middle Eastern Patients With Stroke (Jo-SMMART Study)","JoSMMART","Inclusion Criteria:\n\n* Diagnosis of stroke upon admission to the hospital\n* Adult aged 18 years or older\n* Available lipid profile on hospital admission\n\nExclusion Criteria:\n\n* Stroke diagnosis unconfirmed\n* age younger than 18 years\n* No available lipid profile on admission","18 Years",{"count":18,"type":19},"OBSERVATIONAL","Stroke is a well-known a leading cause of death and disability in the Middle East. There remain many knowledge gaps in evaluating the prevalence of risk factors among patients with stroke in the Middle East. Unravelling the impact of these risk factors and controlling them can positively lower the incidence of stroke. Disparities in stroke risk factors, may well be related to ethnicity of the Middle Eastern populations , will be compared with those among stroke patients in the western literature.",[60,28,61],"Stroke","Risk Factors",[60,63],"Risk factors","2025-12-22",{"date":66,"type":39},"2025-12-23",{"date":68,"type":19},"2025-12-31",{"date":70,"type":19},"2027-01-31",{"name":72,"class":46},"Jordan Collaborating Cardiology Group",1,"Low Density Lipoprotein Cholesterol Level"]